...including if they have ever had problems with low blood pressure or blood circulation. Revatio is not recommended for patients taking ritonavir or antifungal medicines, such as ketoconazole and itraconazole. If patients are taking Revatio...

In this article: Sildenafil, Hypertension, FDA, PDE5 Inhibitor, Chest pain, Pfizer, Warfarin, European Medicines Agency, Ritonavir, and Phenytoin

...that took her in. An 8-year-old German girl does her homework in a children's home called the Ark. A South African boy of 5 is saved by AIDS drugs. PORT-AU-PRINCE , Haiti - Saintia Pierre was born in a country forged by a slave rebellion.

In this article: United Nations, Beijing, Unicef, AIDS Drugs, Convention on the Rights of the Child, and The Miami Herald

...calls for study participants to be randomized to receive either the TCAD therapy comprised of amantadine and ribavirin with oseltamivir or oseltamivir monotherapy for 10 days. The follow-up period will be six months following treatment and an...

In this article: Influenza, Oseltamivir, Ribavirin, Amantadine, Neuraminidase inhibitor, California, HIV, and University of Amsterdam

... Aaron Motsoaledi , have said bluntly that past policies were wrong. Motsoaledi has set a target of getting 80 percent of those who need AIDS drugs on them by 2011. Fanning , the U.S. Embassy health chief, said the U.S. was gearing up to help...

In this article: AIDS, HIV, George W. Bush, South Africa, Jacob Zuma, and Barack Obama

...Phase 2b study conducted by Roche of ITMN-191 (RG7227) combined with standard of care (SOC) PEGASYS® (peginterferon alfa-2a) and COPEGUS ® ( ribavirin ) in HCV treatment-naive patients has been modified. The Phase 2b study has four dosage...

In this article: Pegasys, Ribavirin, Protease inhibitor, SEC, Medical advice, Annual report, Ritonavir, and Securities Exchange Act of 1934

...12 hours -- as a combination therapy. ITMN-191 was given to patients in combination with the current standard-of-care Pegasys and Copegus. To date, about 175 patients have been enrolled in the study. InterMune said the company and its...

In this article: Hepatitis, Pegasys, Copegus, Transaminase, Alanine, Nasdaq, and Brisbane, California

...are investigating the possible role of this virus in the symptomatology of the disease using Ampligen (R) as an investigational therapeutic. Hemispherx Biopharma , Inc. is an advanced specialty pharmaceutical company engaged in the...

In this article: Ampligen, Food and Drug Administration, Retrovirus, Alferon LDO, Chronic fatigue syndrome, Nucleic acid, Federal Food, Drug, and Cosmetic Act, and Sexually transmitted disease

...entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs. Like all retroviruses , the AIDS virus (HIV ) integrates its DNA into the genome of the...

In this article: HIV, Retrovirus, Integrase, Medical advice, Reverse transcriptase inhibitors, Protease inhibitors, AIDS Drugs, and AIDS

... Schuchat said. The CDC said doctors need to treat severe cases quickly with antiviral drugs such as Tamiflu , made by Roche AG , Relenza , made by GlaxoSmithKline or for especially grave hospitalized cases, peramivir , made by BioCryst.

In this article: United States, Relenza, Peramivir, Tamiflu, GlaxoSmithKline, and U.S. Centers for Disease Control and Prevention

...regimen. The current standard of care is to co-administer all HIV protease inhibitors with ritonavir , except in patients who cannot tolerate ritonavir. The multiple ascending dose phase is a randomized, double-blind, placebo-controlled...

In this article: HIV, Ritonavir, Concert Pharmaceuticals, Protease inhibitor, GlaxoSmithKline, Atazanavir, Strategic alliance, Medical advice, Hydrogen atom, and Terrence Higgins Trust

...leadership tenure Pfizer discovered and/or developed a number of important new medicines including Tarceva , Chantix , Zoloft (PTSD), Selzentry and Lyrica along with a number of other medicines currently in late stage development for cancer ,...

In this article: Pfizer Inc, University of New Hampshire, Boston College, Chemistry, and New England School of Law

...or every 12 hours in combination with standard of care Peg-IFN alfa-2a ( Pegasys ®) and ribavirin (Copegus ®) or Peg-IFN alfa2b (PegIntron®) and ribavirin (Rebetol®) in treatment-naive patients with chronic genotype 1 HCV infection. The...

In this article: Telaprevir, Ribavirin, Hepatitis, Pegasys, American Association, Rash, Tibotec, Medical advice, and Cancer

...of seven potential treatments, five of which are in phase II development. Dr Limet highlighted the potential of Pfizer 's anti-viral drug Selzentry , which stimulates the patient's immune system, as a growth driver. The merged HIV...

In this article: HIV, GlaxoSmithKline, Pfizer, Revenue, Selzentry, and London

...of Liver Diseases' annual meeting in Boston. Vierling said 85 to 87 percent of patients who took narlaprevir, ritonavir , Pegintron and ribavirin after lead-in treatment also achieved early virologic response (EVR), defined as undetectable...

In this article: Hepatitis, Ribavirin, Schering-Plough, Telaprevir, Boceprevir, American Association, Ritonavir, and HIV

...on one of the related terms atop a news story and you'll get a page listing all the stories featuring that term. Vertex says telaprevir boosted hepatitis response CAMBRIDGE , Mass. Vertex Pharmaceuticals Inc. said Wednesday its...

In this article: Telaprevir, Vertex, Hepatitis, Cambridge, and Massachusetts

... EU. Corifollitropin Alfa, Mometasone Formoterol or [Dalera] and Nomac/E2 and we also filed a new version of Implanon. Meanwhile for Vicriviroc we plan to have a key FDA meeting this quarter before we initiate the rolling NDA process. In Japan...

In this article: Schering-Plough, Fred Hassan, FDA, Merck, Boceprevir, Nasonex, Sugammadex, and Temodar

...percent of treatment-naive patients have virus that uses the CCR5 co-receptor.(3) The study evaluates vicriviroc 30 mg once-daily in combination with ritonavir -boosted atazanavir,(4) compared to a control group receiving Truvada...

In this article: Vicriviroc, Schering-Plough, HIV, Ritonavir, CCR5, Truvada, Protease inhibitor, Atazanavir, Nucleoside, and Bristol-Myers Squibb Company

...Phase III clinical studies in treatment-experienced HIV patients. Key Safety Findings with Vicriviroc A pooled data analysis was conducted for two vicriviroc Phase II studies involving 205 treatment-experienced HIV -infected patients who...

In this article: Vicriviroc, HIV, Schering-Plough, Atazanavir, Truvada, Ritonavir, Reverse transcriptase inhibitor, CCR5, Nucleoside, and Myocardial infarction